Oncocyte CORP (IMDX) — DEF 14A Filings
All DEF 14A filings from Oncocyte CORP. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Oncocyte Corp Files Definitive Proxy Statement
— May 14, 2025 Risk: low
Oncocyte Corp filed a Definitive Proxy Statement (DEF 14A) on May 14, 2025. The filing indicates no fee was required for this submission. The company's principa -
Oncocyte Corp Files Definitive Proxy Statement
— Sep 25, 2024 Risk: low
Oncocyte Corp filed a Definitive Proxy Statement (DEF 14A) on September 25, 2024. The filing indicates no fee was required for this submission. The company, pre -
Oncocyte Corp Schedules 2024 Annual Shareholder Meeting
— Apr 29, 2024 Risk:
Oncocyte Corp (IMDX) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 Annual Meeting of Shareholders for Oncocyte Corporation will be
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX